Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Oncology

Background:

• Contrast-enhanced MRI lymphography aids in detecting lymph node (LN) alterations in diseases like cancer.
• Traditional MRI lymphography uses low molecular weight gadolinium agents, which may limit specificity and sensitivity.
• Larger gadolinium-loaded nanoparticles offer potential for improved lymphography performance.

Purpose of the Study:

• To compare the efficacy of three gadolinium contrast agents of varying sizes and properties for MRI lymphography.
• To assess the agents' ability to identify tumor-induced alterations in lymph drainage patterns.
• To evaluate the potential for nanoparticle contrast agents in targeted therapy delivery to tumor-draining LNs.

Main Methods:

• Subcutaneous injection of three gadolinium contrast agents (varying sizes/properties) in mice.
• 3T MRI imaging of tumor-bearing mice (B16-F10 melanoma) to assess lymph drainage.
• Comparison of contrast agent distribution in tumor-draining (popliteal, inguinal) LNs versus contralateral LNs.

Main Results:

• Gadolinium lipid nanoparticles successfully identified tumor-induced drainage alterations into popliteal LNs.
• Lower molecular weight or albumin-binding gadolinium agents showed less effectiveness.
• Contrast agents localized to the cortex and medulla of tumor-draining popliteal LNs, but only the cortex of non-draining LNs.
• Reduced uptake in second-tier inguinal LNs suggests tumors can divert LN drainage.

Conclusions:

• Gadolinium lipid nanoparticles enhance MRI lymphography for detecting tumor-induced lymph drainage changes.
• MRI lymphography using nanoparticles can aid in diagnosing LN pathology in cancer.
• Preferential uptake of nanoparticle contrast agents in tumor-draining LNs enables targeted therapy delivery.